Table 1 Baseline characteristics of the cohort.
From: Residual ST-segment elevation to predict long-term clinical and CMR-derived outcomes in STEMI
All patients (n = 488) | MACE | p | ||
|---|---|---|---|---|
Yes (n = 92) | No (n = 396) | |||
Age (years) | 58.85 ± 12.43 | 65.63 ± 12.58 | 57.28 ± 11.86 | < 0.001 |
Male sex | 392 (80.3) | 68 (73.9) | 324 (81.8) | 0.1 |
Smoker | 279 (57.2) | 45 (48.9) | 234 (59.1) | 0.08 |
Hypertension | 229 (46.9) | 56 (60.9) | 173 (43.7) | 0.003 |
Hypercholesterolemia | 212 (43.4) | 43 (46.7) | 169 (42.3) | 0.479 |
Diabetes mellitus | 96 (19.7) | 22 (23.9) | 74 (18.7) | 0.25 |
Previous CAD | 37 (7.5) | 13 (14.1) | 24 (6) | 0.01 |
Killip class | ||||
I | 419 (85.8) | 67 (72.8) | 352 (88.9) | < 0.001 |
≥ II | 69 (14.1) | 25 (27.2) | 44 (11.1) | |
GRACE risk score | 141.1 ± 28.44 | 161.32 ± 32.38 | 136.4 ± 25.26 | < 0.001 |
Heart rate (bpm) | 79.52 ± 20.35 | 84.78 ± 22.71 | 78.3 ± 19.59 | 0.006 |
Systolic pressure (mmHg) | 130.42 ± 29.66 | 128.45 ± 38.73 | 130.88 ± 29.18 | 0.479 |
Localization | ||||
Anterior | 246 (50.4) | 60 (65.2) | 186 (47) | 0.002 |
Inferior | 190 (38.9) | 29 (31.5) | 161 (40.6) | |
Lateral | 52 (10.7) | 3 (3.3) | 49 (12.4) | |
Multivessel disease | 124 (25.4) | 34 (36.9) | 90 (22.7) | 0.005 |
Time to revascularization (min) | 190 [130–300] | 220 [150–402] | 180 [120–300] | 0.01 |
TIMI flow grade before pPCI | ||||
0 | 231 (47.3) | 45 (48.9) | 186 (47) | 0.71 |
1 | 33 (6.8) | 8 (8.7) | 25 (6.3) | |
2 | 55 (11.3) | 8 (8.7) | 47 (11.9) | |
3 | 169 (34.6) | 31 (33.7) | 138 (34.8) | |
TIMI flow grade after pPCI | ||||
0 | 9 (1.8) | 4 (4.3) | 5 (1.3) | 0.012 |
1 | 3 (0.6) | 1 (1.1) | 2 (0.5) | |
2 | 31 (6.4) | 11 (12) | 20 (5) | |
3 | 445 (91.2) | 76 (82.6) | 370 (93.4) | |
Medical treatment at discharge | ||||
Dual antiplatelet therapy | 456 (93.4) | 85 (92.4) | 371 (93.7) | 0.64 |
Oral anticoagulation | 67 (13.7) | 15 (16.3) | 52 (13.1) | 0.41 |
Beta blockers | 359 (73.6) | 59 (64.1) | 300 (75.8) | 0.026 |
Angiotensin-converting-enzyme inhibitors | 262 (53.7) | 44 (47.8) | 218 (55.1) | 0.25 |
Angiotensin receptor blockers | 114 (23.4) | 23 (25) | 91 (23) | 0.68 |
Mineralocorticoid receptor antagonist | 55 (11.3) | 24 (26.1) | 31 (7.8) | < 0.001 |
Statins | 429 (87.9) | 78 (84.8) | 351 (88.6) | 0.29 |
Diuretics | 63 (12.9) | 30 (32.6) | 33 (8.3) | < 0.001 |
